DeepHealth and CARPL.ai have established a strategic collaboration to create a unique Artificial Intelligence (AI) control system for image interpretation to ensure AI scalability, performance ...

Truist raised the firm’s price target on RadNet (RDNT) to $94 from $80 and keeps a Buy rating on the shares. The firm, which is updating its estimates to reflect Q3 earnings, raised FY24 guidance and ...

Maverick Medical AI Announces Completion of The Implementation of Its Real-Time Autonomous Medical Coding Solution at RadNet ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $83.25, ...

Sawtelle-based medical imaging company RadNet Inc. is going even deeper into the use of artificial intelligence. On Nov. 11, ...

DeepHealth, a wholly-owned subsidiary of RadNet (RDNT), has received expanded FDA 510(k) clearance for its mammography software. SmartMammo Dx, ...

LOS ANGELES, Nov. 22, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost ...

Mutual of America Capital Management LLC cut its position in shares of RadNet, Inc. (NASDAQ:RDNT – Free Report) by 10.4% ...

鉴于最近的发展，Truist Securities已经修订了RadNet 2024年至2026年的调整后EBITDA估计。新的估计为2024年$280.4百万，高于先前的$274.0百万估计。2025年和2026年的估计分别上调至$308.0百万和$336.0百万，高于先前的$300.0百万和$325.0百万预测。

The raised price target and maintained Buy rating reflect a positive outlook on RadNet (NASDAQ:RDNT)'s financial health and growth potential, particularly in the wake of its third-quarter performance ...

4 analysts have expressed a variety of opinions on RadNet (NASDAQ:RDNT) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below provides a snapshot of ...

The clearance enables RadNet’s DeepHealth and GE HealthCare collaboration to bring together the SmartMammo and Senographe Pristina solutions and transform breast cancer diagnosis. SOMERVILLE ...